Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

March 30, 2019

Conditions
Safety Issues
Interventions
BIOLOGICAL

Rotavirus (Bio Farma) Vaccine

Rotavirus (Bio Farma) Vaccine

OTHER

Placebo

Placebo contains 30% sucrose in DMEM

Trial Locations (4)

Unknown

Gantiwarno Primary Health Center, Klaten

Klaten Selatan Primary Health Center, Klaten

Ngawen Primary Health Center, Klaten

RS Soeradji Tritonegoro, Klaten

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PT Bio Farma

INDUSTRY